News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
430,293 Results
Type
Article (21195)
Company Profile (139)
Press Release (408938)
Multimedia
Podcasts (119)
Webinars (24)
Section
Business (133172)
Career Advice (1408)
Deals (23671)
Drug Delivery (107)
Drug Development (45462)
Employer Resources (145)
FDA (9070)
Job Trends (9955)
News (217639)
Policy (19849)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (4)
Academia (1010)
Accelerated approval (27)
Adcomms (12)
Allergies (107)
Alliances (35424)
ALS (95)
Alzheimer's disease (884)
Antibody-drug conjugate (ADC) (252)
Approvals (9363)
Artificial intelligence (502)
Autoimmune disease (145)
Automation (43)
Bankruptcy (192)
Best Places to Work (7302)
BIOSECURE Act (19)
Biosimilars (172)
Biotechnology (73)
Bladder cancer (83)
Brain cancer (46)
Breast cancer (341)
Cancer (2740)
Cardiovascular disease (247)
Career advice (1210)
Career pathing (38)
CAR-T (153)
CDC (29)
Celiac Disease (1)
Cell therapy (461)
Cervical cancer (29)
Clinical research (40117)
Collaboration (1472)
Company closure (3)
Compensation (534)
Complete response letters (56)
COVID-19 (1228)
CRISPR (68)
C-suite (920)
Cystic fibrosis (94)
Data (3691)
Decentralized trials (2)
Denatured (42)
Depression (89)
Dermatology (43)
Diabetes (260)
Diagnostics (3637)
Digital health (30)
Diversity (8)
Diversity, equity & inclusion (32)
Drug discovery (242)
Drug pricing (176)
Drug shortages (22)
Duchenne muscular dystrophy (147)
Earnings (49561)
Editorial (60)
Employer branding (17)
Employer resources (122)
Events (62567)
Executive appointments (920)
FDA (11139)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (17)
Funding (982)
Gene editing (126)
Generative AI (52)
Gene therapy (397)
GLP-1 (645)
Government (2441)
Grass and pollen (5)
Guidances (286)
Healthcare (8415)
HIV (32)
Huntington's disease (23)
IgA nephropathy (60)
Immunology and inflammation (119)
Immuno-oncology (42)
Indications (116)
Infectious disease (1396)
Inflammatory bowel disease (115)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (182)
Interviews (222)
IPO (9364)
IRA (53)
Job creations (2866)
Job search strategy (1017)
JPM (51)
Kidney cancer (14)
Labor market (91)
Layoffs (302)
Leadership (36)
Legal (4709)
Liver cancer (44)
Longevity (16)
Lung cancer (396)
Lymphoma (222)
Machine learning (44)
Management (45)
Manufacturing (854)
MASH (127)
Medical device (6140)
Medtech (6196)
Mergers & acquisitions (15226)
Metabolic disorders (797)
mRNA (100)
Multiple sclerosis (83)
NASH (15)
Neurodegenerative disease (194)
Neuropsychiatric disorders (61)
Neuroscience (1656)
Neurotech (1)
NextGen: Class of 2026 (3650)
Non-profit (1529)
Now hiring (37)
Obesity (389)
Opinion (291)
Ovarian cancer (114)
Pain (172)
Pancreatic cancer (123)
Parkinson's disease (182)
Partnered (24)
Patents (375)
Patient recruitment (267)
Peanut (20)
People (45939)
Pharmaceutical (64)
Pharmacy benefit managers (30)
Phase 1 (11020)
Phase 2 (17255)
Phase 3 (14680)
Pipeline (5082)
Policy (268)
Postmarket research (1532)
Preclinical (4562)
Press Release (60)
Prostate cancer (154)
Psychedelics (31)
Radiopharmaceuticals (230)
Rare diseases (644)
Real estate (4332)
Recruiting (63)
Regulatory (15714)
Reports (43)
Research institute (1108)
Resumes & cover letters (230)
Rett syndrome (14)
RNA editing (11)
RSV (34)
Schizophrenia (108)
Series A (181)
Series B (125)
Service/supplier (4)
Sickle cell disease (67)
Special edition (24)
Spinal muscular atrophy (100)
Sponsored (33)
Startups (2557)
State (2)
Stomach cancer (9)
Supply chain (95)
Tariffs (94)
The Weekly (74)
Vaccines (440)
Venture capital (86)
Weight loss (229)
Women's health (75)
Worklife (18)
Date
Today (48)
Last 7 days (355)
Last 30 days (1905)
Last 365 days (16513)
2026 (7070)
2025 (16938)
2024 (19861)
2023 (22821)
2022 (31492)
2021 (33267)
2020 (31907)
2019 (27865)
2018 (21195)
2017 (20624)
2016 (19598)
2015 (22867)
2014 (18024)
2013 (15488)
2012 (17074)
2011 (17612)
2010 (15552)
Location
Africa (524)
Alabama (37)
Alaska (5)
Arizona (163)
Arkansas (7)
Asia (36314)
Australia (4916)
California (6395)
Canada (2435)
China (985)
Colorado (261)
Connecticut (292)
Delaware (199)
Europe (60903)
Florida (1094)
Georgia (176)
Hawaii (2)
Idaho (32)
Illinois (749)
India (78)
Indiana (397)
Iowa (17)
Japan (486)
Kansas (106)
Kentucky (31)
Louisiana (22)
Maine (21)
Maryland (796)
Massachusetts (4785)
Michigan (214)
Minnesota (374)
Mississippi (4)
Missouri (69)
Montana (14)
Nebraska (23)
Nevada (54)
New Hampshire (54)
New Jersey (2303)
New Mexico (14)
New York (1948)
North Carolina (1104)
North Dakota (9)
Northern California (3056)
Ohio (221)
Oklahoma (14)
Oregon (25)
Pennsylvania (1317)
Puerto Rico (19)
Rhode Island (32)
South America (834)
South Carolina (42)
Southern California (2657)
Tennessee (103)
Texas (961)
United States (24570)
Utah (155)
Vermont (1)
Virginia (240)
Washington D.C. (58)
Washington State (441)
West Virginia (4)
Wisconsin (90)
Wyoming (1)
430,293 Results for "taro pharmaceutical industries ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced that it has called an extraordinary general meeting of its shareholders (the “Extraordinary General Meeting”), to be held on May 22, 2024, at 10:00 a.m., Israel time.
April 15, 2024
·
7 min read
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Deals
Sun Pharma Completes Taro Merger
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) with its subsidiary.
June 24, 2024
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service
May 6, 2026
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Results of the Annual General Meeting
May 4, 2026
·
6 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Deals
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024.
May 23, 2024
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Director Dealing
March 19, 2026
·
3 min read
Press Releases
Notice of Faron Pharmaceuticals LTD’s Annual General Meeting
April 10, 2026
·
17 min read
Biotech Beach
Taro Provides Results for Year Ended March 31, 2024
Taro Pharmaceutical Industries Ltd. provided unaudited financial results for the quarter and year ended March 31, 2024.
May 20, 2024
·
9 min read
1 of 43,030
Next
